EVITA Trial Finds Vitamin C Fails to Meet CCUS and MDS Endpoints
Oral vitamin C supplementation failed to hit its primary efficacy endpoints in a phase 2 trial involving patients with clonal cytopenia of undetermined significance (CCUS) or lower-risk myeloid malignancies, though ... Read More